| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.0085 |
0.9 |
| mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |